Cargando…

Gill JC, Castaman G, Windyga J, et al. Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease. Blood. 2015;126(17):2038-2046.

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2016
Materias:	Errata
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891959/ https://www.ncbi.nlm.nih.gov/pubmed/31265496 http://dx.doi.org/10.1182/blood-2016-04-711259

Ejemplares similares

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease
por: Casonato, Alessandra, et al.
Publicado: (2016)

Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease
por: Castaman, Giancarlo
Publicado: (2013)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
por: Manderstedt, Eric, et al.
Publicado: (2018)

Schleicher RI, Reichenbach F, Kraft P, et al. Platelets induce apoptosis via membrane-bound FasL. Blood. 2015;126(12):1483-1493.
Publicado: (2016)

Von Willebrand Disease: An Overview
por: Bharati, K. Pavani, et al.
Publicado: (2011)

On the Versatility of von Willebrand Factor
por: Rauch, Antoine, et al.
Publicado: (2013)

Of von Willebrand factor and platelets
por: Bryckaert, Marijke, et al.
Publicado: (2014)

Up to date concepts about Von Willebrand disease and the diagnose of this hemostatic disorder
por: Buga-Corbu, I, et al.
Publicado: (2014)

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010)

Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
por: Favaloro, Emmanuel J.
Publicado: (2020)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
por: Vangenechten, Inge, et al.
Publicado: (2020)

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome
por: Deconinck, Shannen, et al.
Publicado: (2018)

von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis
por: Kalot, Mohamad A., et al.
Publicado: (2021)

Acquired von Willebrand syndrome in monoclonal gammopathy – A scoping review on hemostatic management
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2021)

Treatment of patients with von Willebrand disease
por: Tuohy, Emma, et al.
Publicado: (2011)

The Molecular Genetics of von Willebrand Disease
por: Berber, Ergül
Publicado: (2012)

Von Willebrand Factor, Angiodysplasia and Angiogenesis
por: Randi, Anna M., et al.
Publicado: (2013)

Regulation of plasma von Willebrand factor
por: Desch, Karl C
Publicado: (2018)

Von Willebrand's Disease: Pathogenesis and Management
por: Dormandy, Katharine M.
Publicado: (1969)

Report on von Willebrand Disease in Malaysia
por: Periayah, Mercy Halleluyah, et al.
Publicado: (2016)

Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232.
Publicado: (2015)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
por: Boender, Johan, et al.
Publicado: (2021)

Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
por: Casonato, Alessandra, et al.
Publicado: (2021)

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
por: Leebeek, Frank W. G., et al.
Publicado: (2022)

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2016)

In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor
por: Colling, Meaghan E., et al.
Publicado: (2019)

A Comparative Evaluation of an Automated Functional Assay for Von Willebrand Factor Activity in Type 1 Von Willebrand Disease
por: Lai, Shiue-Wei, et al.
Publicado: (2021)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
por: Gritsch, Herbert, et al.
Publicado: (2022)

Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
por: Bauer, Alexander, et al.
Publicado: (2023)

Outcomes in Patients With von Willebrand Disease Receiving Recombinant von Willebrand Factor on Demand and in Surgical Settings: Chart Review
por: Sun, Shawn X., et al.
Publicado: (2023)

Evaluation of von Willebrand factor in COPD patients
por: Bártholo, Thiago Prudente, et al.
Publicado: (2014)

Treatment of patients with von Willebrand disease [Erratum]
Publicado: (2013)

Von Willebrand disease in the elderly: clinical perspectives
por: Chapin, John
Publicado: (2018)

Acquired von Willebrand syndrome: focused for hematologists
por: Franchini, Massimo, et al.
Publicado: (2020)

Impact of Von Willebrand Factor on Bacterial Pathogenesis
por: Steinert, Michael, et al.
Publicado: (2020)

The Manifold Cellular Functions of von Willebrand Factor
por: Mojzisch, Angelika, et al.
Publicado: (2021)

Endothelial Function in Patients With Von Willebrand Disease
por: Noone, Stephanie, et al.
Publicado: (2021)

Prophylactic management of patients with von Willebrand disease
por: Franchini, Massimo, et al.
Publicado: (2021)

Analysis of von Willebrand Disease in the “Heart of Europe”
por: Vangenechten, Inge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_po1klo3be2kvmtr8uudgm6ftij